Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.6024
Delayed Data
As of Jul 22
 +0.006 / +1.01%
Today’s Change
0.55
Today|||52-Week Range
3.66
-77.27%
Year-to-Date
Varian (VAR): What's in Store for the Stock in Q3 Earnings?
Jul 22 / Zacks.com - Paid Partner Content
Adeptus Health (ADPT) Q2 Earnings: Will it Beat Estimates?
Jul 18 / Zacks.com - Paid Partner Content
C.R. Bard (BCR) Well Poised to Beat Q2 Earnings Estimates?
Jul 21 / Zacks.com - Paid Partner Content
St. Jude Medical (STJ) Q2 Earnings: What's in the Cards?
Jul 15 / Zacks.com - Paid Partner Content
Can CryoLife (CRY) Earnings Spring a Surprise in Q2?
Jul 21 / Zacks.com - Paid Partner Content
Intuitive Surgical (ISRG) Q2 Earnings: What's in Store?
Jul 15 / Zacks.com - Paid Partner Content
CytRx (CYTR) Is in Oversold Territory: What's Next?
Jul 20 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx
Jul 14 / Zacks.com - Paid Partner Content
Sarepta (SRPT) Posts Y/Y Wider Q2 Loss, Eteplirsen in Focus
Jul 20 / Zacks.com - Paid Partner Content
Juno Therapeutics (JUNO) in Focus: Stock Gains 9.5%
Jul 14 / Zacks.com - Paid Partner Content
Merck KGaA's Multiple Sclerosis Drug under Review in EU
Jul 19 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for July 14th
Jul 14 / Zacks.com - Paid Partner Content
Evoke (EVOK) Stock Down on Poor Phase III EVK-001 Data
Jul 19 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel ...
Jul 13 / Zacks.com - Paid Partner Content
athenahealth (ATHN) Q2 Earnings: What's in the Cards?
Jul 18 / Zacks.com - Paid Partner Content
CytRx (CYTR) Stock Falls on Unfavorable Aldoxorubicin Data
Jul 13 / Zacks.com - Paid Partner Content